laruparetigene zovaparvovec

all catalysts(0)

nothing on the calendar yet

News(2)

• Beacon eye gene therapy hits mark in late-stage study
  Beacon claimed the findings represent the first time a treatment for X-linked retinitis pigmentosa, a rare and potentially blinding condition, met its main goal in a pivotal trial.
  biopharma_dive · 12d ago
• Beacon lights path to FDA approval with pivotal trial win for rare vision loss gene therapy
  Beacon Therapeutics has found the light in a rare vision loss disease that has left larger companies in the dark. The biotech’s gene therapy for X-linked retinitis pigmentosa (XLRP) successfully im…
  fiercebiotech · 13d ago